Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era

Graft-versus-host disease (GVHD) is one of the leading causes of nonrelapse mortality (NRM) after allogeneic hematopoietic cell transplantation (allo-HCT). Posttransplant cyclophosphamide (PTCy) has shown promise in managing GVHD. However, cyclophosphamide has known cardiac toxicity, and few studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Jason, Whited, Laura, Saliba, Rima M., Rondon, Gabriela, Banchs, Jose, Shpall, Elizabeth, Champlin, Richard, Popat, Uday
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714723/
https://www.ncbi.nlm.nih.gov/pubmed/34592759
http://dx.doi.org/10.1182/bloodadvances.2021004846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714723/
https://www.ncbi.nlm.nih.gov/pubmed/34592759
http://dx.doi.org/10.1182/bloodadvances.2021004846

Ejemplares similares